FDA's Advisory Cmte. Meeting On Bladder Pain Syndrome May Signal Policy Changes

 
• By Derrick Gingery
  
FDA entrance sign 2016
The advisory committee meeting could lead to policy changes in painful bladder syndrome.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers